Pharmaceuticals for Women's Health: Global Markets

Sep 2020| PHM203B| BCC Publishing

Report Highlights

The global market for women’s health therapeutics should grow from $31.5 billion in 2019 to $41.2 billion by 2025, at a compound annual growth rate (CAGR) of 4.7% for the period of 2019-2025.

Report Includes

  • 54 tables
  • Detailed overview of the global markets for pharmaceuticals for women's health and identification of the main women's health disorders
  • Analyses of market trends, with data from 2019, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
  • Evaluation of the impact of demographic, economic and other factors that will drive future demand in the women's health therapeutics market
  • A look at the unmet needs in women’s health therapeutics and details of the promising new drugs and therapies that are still in development and testing stage
  • Market forecast of the potential drugs in the pipeline, information on late-stage pipeline drugs and overview of osteoporosis drug development
  • Insights into government concerns and initiatives towards women’s health
  • Highlights of current and future market potential and a detailed analysis of the current market size, and regulatory scenarios
  • Market share analysis of leading drug manufacturers and detailed coverage of women's health therapeutics industry in terms of different events like mergers and acquisitions, agreements, collaborations, and partnerships
  • Company profiles of the leading suppliers of the industry including AbbVie Inc., Bayer AG, Daiichi Sankyo Co. Ltd., Eli Lilly and Co., Johnson & Johnson Inc. and Merck KGaA

Report Scope

While women’s health encompasses several health issues, this report will focus on menopause-related disorders, postmenopausal osteoporosis, endometriosis, polycystic ovarian syndrome and pregnancy disorders. This report does not focus on drugs for infertility, diagnostic and drug technologies for breast cancer or therapies and diagnostics for ovarian cancer. However, we have individual reports that discuss the scope of these health concerns in detail. The report codes for these reports are listed below:

PHM194A Drugs for Infertility: Global Markets

HLC143B Therapies and Diagnostics for Ovarian Cancer: Global Markets

HLC209A U.S. Fertility Clinics Market

HLC106D Breast Cancer Diagnostic and Drug Technologies: Global Markets.

Frequently Asked Questions (FAQs)

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Latest reports include:

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Pharmaceuticals for Women's Health: Global Markets140Free
Chapter- 1: Introduction7Free
Chapter- 2: Summary and Highlights2Free
Chapter- 3: Technologies and Global Markets Overview11Free
Chapter- 4: Pipeline Assessment and Analysis6Free
Chapter- 5: Regulatory Structure7Free
Chapter- 6: Market Breakdown by Women’s Health Condition, Disorder and Disease39Free
Chapter- 7: Market Breakdown by Region30Free
Chapter- 8: Competitive Landscape and Key Developments7Free
Chapter- 9: Company Profiles27Free
Chapter- 10: Appendix: Glossary and Acronyms4Free
Published - Aug-2018| Analyst - BCC Publishing| Code - PHM203A

Report Highlights

The global market for women’s health therapeutics reached nearly $30.5 billion in 2018 and should reach nearly $37.3 billion by 2023, at a compound annual growth rate (CAGR) of 4.2% for the period of 2018-2023. 

Report Includes

  • 26 data tables and 34 additional tables
  • Detailed overview of the global markets for pharmaceuticals for women's health
  • Country specific data and analysis for United States, Mexico, Germany, U.K., France, China, India, Japan, Middle East and Africa
  • A look at the regulatory environment which has been a driving force in the drug development industry
  • Information on competitor initiatives, and information with regard to demand for specialty chemicals used to develop new products and for new applications
  • A relevant patent analysis within the sector
  • Comprehensive company profiles of major Players in the Market including AbbVie Inc., Allergan PLC, Amgen Inc., Bayer Ag., Eli Lilly and Company, Johnson & Johnson Inc., Novo Nordisk and Pfizer Inc.
Pharmaceuticals for Women's Health: Global Markets

Single User License: $2750

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
RELATED REPORTS